| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.31 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |